Janus Henderson Group’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
ACM
CAM
SI
OCA
RCM
VCM
B
PCH
Janus Henderson Group's BIOA Position: Q1 2026 in Review
Janus Henderson Group increased its BioAge Labs (BIOA) stake by 412% in Q1 2026, buying an estimated $32.4M and bringing the position to 2,094,270 shares worth $36.6M. The position accounts for 0.02% of the portfolio, ranked #467.
Janus Henderson Group first reported a position in BIOA in Q4 2025 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.
- Janus Henderson Group held 2,094,270 shares of BioAge Labs worth $36.6M as of Q1 2026.
- Janus Henderson Group bought 1,685,063 BioAge Labs shares in Q1 2026, an estimated $32.4M.
- BioAge Labs made up 0.02% of Janus Henderson Group's portfolio in Q1 2026, its #467 holding.
- Janus Henderson Group first reported a position in BioAge Labs in Q4 2025 and has held it in 2 quarters since.
- 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.